Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
1
x
$
30.00
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study
1
x
$
30.00
Letter From the Editors: A Question of Ownership
1
x
$
0.00
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
1
x
$
30.00
Mechanism of Action of Antidepressants
1
x
$
30.00
VOL 2 No. 2 Full Issue - February 2000
1
x
$
20.00
Atomoxetine Induced Hypothermia by Onat Yilmaz
1
x
$
30.00
Sleep Deprivation & Amphetamine Induced Psychosis
1
x
$
30.00
Zung Self-Rating Depression Scale
1
x
$
0.00
Mikael Landén, MD, PhD: Treatment Refractory Psychosis Remitted Upon Treatment with Continuous Positive Airway Pressure: A Case Report
1
x
$
30.00
Recognition and Treatment of Anxiety Disorders in Primary Care
1
x
$
0.00
Joyce E. Myers, MD: Risperidone: Review of Its Therapeutic Utility in Depression
1
x
$
30.00
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj
1
x
$
30.00
2018 Update: Dosing and Monitoring: Children and Adolescents
1
x
$
30.00
View Cart
Checkout
Home
adolescents
“2018 Update: Dosing and Monitoring: Children and Adolescents” has been added to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
The Use of Prazosin in Treatment of Drug Dreams in Adolescents with Substance Use Disorder: Two Case Reports (OPEN ACCESS)
$
0.00
Add to cart
Details
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
$
0.00
Add to cart
Details
NEWLY UPDATED — Psychotropic Dosing and Monitoring: Children and Adolescents – Digital PDF
$
30.00
Add to cart
Details
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Ken Gersing, MD: Predicting Antipsychotic Use in Children
$
30.00
Add to cart
Details
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
$
30.00
Add to cart
Details
Jefferson B. Prince, MD: Citalopram for the Treatment of Adolescent Anxiety Disorders: A Pilot Study
$
30.00
Add to cart
Details
2018 Update: Dosing and Monitoring: Children and Adolescents
$
30.00
Add to cart
Details
Treatment-Resistant Juvenile Depression—A Quicksand?
$
30.00
Add to cart
Details
Exploring the Interplay of Sleep and Nicotine Vaping in Adolescents: An Evidence-Based Narrative Review
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 38 Supplement No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Page load link
Go to Top
